Last edition
News about "Devashish Singh"
MrMed Reports 123 Percent Revenue Growth to INR 74.3 Crore in FY26
MrMed records INR 74.3 crore revenue and closed FY26 EBITDA positive, with most revenue coming from non-metro markets.
Devashish Singh | 01/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members